Search

Your search keyword '"Leiz, Steffen"' showing total 170 results

Search Constraints

Start Over You searched for: Author "Leiz, Steffen" Remove constraint Author: "Leiz, Steffen"
170 results on '"Leiz, Steffen"'

Search Results

1. De novo variants in GABRA4 are associated with a neurological phenotype including developmental delay, behavioral abnormalities and epilepsy

3. Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome

4. De novo variants in GABRA4are associated with a neurological phenotype including developmental delay, behavioral abnormalities and epilepsy

5. High association of MOG-IgG antibodies in children with bilateral optic neuritis

7. Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder

9. MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein

10. Impaired Brain Growth in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Acute Disseminated Encephalomyelitis

11. Effectiveness of antiepileptic therapy in patients with PCDH19 mutations

12. Autoimmune Encephalitis with Autoantibodies to NMDAR1 following Herpes Encephalitis in Children and Adolescents

14. MR imaging in children with transverse myelitis and acquired demyelinating syndromes

15. Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases

16. CAD mutations and uridine-responsive epileptic encephalopathy

17. De novo GABRG2 mutations associated with epileptic encephalopathies

18. Autoimmune Encephalitis with Autoantibodies to NMDAR1 following Herpes Encephalitis in Children and Adolescents.

19. Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases

21. Human COQ4 deficiency: delineating the clinical, metabolic and neuroimaging phenotypes

23. Human COQ4 deficiency: delineating the clinical, metabolic and neuroimaging phenotypes.

24. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients

25. De novo variants in neurodevelopmental disorders—experiences from a tertiary care center

26. Additional file 4 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients

27. Additional file 5 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients

28. Additional file 8 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients

29. Additional file 2 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients

30. Additional file 1 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients

31. Additional file 3 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients

32. Additional file 7 of Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients

36. GLRB is the third major gene of effect in hyperekplexia

37. Impaired Brain Growth in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Acute Disseminated Encephalomyelitis.

39. Expanding the phenotypic and molecular spectrum of RNA polymerase III–related leukodystrophy

41. Failure of Expected Brain Growth in Children with ADEM

42. Frequency of Spinal Cord Involvement and Autoantibody Status in a Large Cohort of Children Presenting with a First Acute Demyelinating Syndrome

43. Epilepsy Surgery in the First Months of Life

45. Epilepsy surgery in the first months of life: a large type IIb focal cortical dysplasia causing neonatal drug‐resistant epilepsy

47. Impact of Hippotherapy on Gross Motor Function and Quality of Life in Children with Bilateral Cerebral Palsy: A Randomized Open-Label Crossover Study

49. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome

50. Reversible epileptic encephalopathy upon uridine treatment in patients with CAD mutations

Catalog

Books, media, physical & digital resources